The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 14, 2010
Filed:
Oct. 17, 2006
Shelley K. Ballentine, Lansdale, PA (US);
Christian Andrew Baumann, Exton, PA (US);
Jinsheng Chen, Exton, PA (US);
Carl R. Illig, Phoenixville, PA (US);
Sanath K. Meegalla, Boothwyn, PA (US);
M. Jonathan Rudolph, Doylestown, PA (US);
Robert W. Tuman, Chalfont, PA (US);
Mark J. Wall, Flourtown, PA (US);
Kenneth Wilson, Media, PA (US);
Dana L. Johnson, Upper Black Eddy, PA (US);
Shelley K. Ballentine, Lansdale, PA (US);
Christian Andrew Baumann, Exton, PA (US);
Jinsheng Chen, Exton, PA (US);
Carl R. Illig, Phoenixville, PA (US);
Sanath K. Meegalla, Boothwyn, PA (US);
M. Jonathan Rudolph, Doylestown, PA (US);
Robert W. Tuman, Chalfont, PA (US);
Mark J. Wall, Flourtown, PA (US);
Kenneth Wilson, Media, PA (US);
Dana L. Johnson, Upper Black Eddy, PA (US);
Janssen Pharmaceutica NV, Beerse, BE;
Abstract
A method of reducing or inhibiting kinase activity of FLT3 in a cell or a subject, and the use of such compounds for preventing or treating in a subject a cell proliferative disorder and/or disorders related to FLT3 using a compound of the present invention: or a solvate, hydrate, tautomer or pharmaceutically acceptable salt thereof.The present invention is further directed to methods for treating conditions such as cancers and other cell proliferative disorders.